Looking to publish in Journal of Infection and Chemotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginJournal of Infection and Chemotherapy is the official journal of the Japanese Society of Chemotherapy, The Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. It welcomes original papers, review papers, laboratory or clinical studies, case reports, notes, committee reports, surveillance, and guidelines on all aspects of chemotherapy, including the pathogenesis, diagnosis, treatment, and control of infection, with particular interest in animal models, pharmacokinetics, epidemiology, and clinical trials.
Looking to publish in Journal of Infection and Chemotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Journal of Infection and Chemotherapy accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review Article
Case Report
Note
Letter To The Editor
Guideline
Recent Publications
Clinical characteristics and antimicrobial stewardship of Pseudomonas aeruginosa and other glucose non-fermenting gram-negative rods in bacteremia
Takahiro Takuma, Masayuki Maeda, Keiko Ishino, Issei Tokimatsu
Distribution of Pathogens and Antimicrobial Resistance Patterns in Urinary Tract Infections Following Radical Cystectomy and Urinary Diversion
Caner Öksüz, İsmail Emre Ergin, Rıdvan Karaarslan, Mustafa Uygunlar, Esat Korğalı, Seyit Ali Büyüktuna
Development and validation of machine learning model for selecting the optimal population pharmacokinetic model for vancomycin
Hayato Akamatsu, Yukinobu Kodama, Ayaka Terai, Masanobu Imamura, Kazutaka Oda, Hirofumi Jono, Kaname Ohyama
Clinical Epidemiology and Risk Factors for Community-Onset Isolation of Extended-Spectrum β-Lactamase-Producing Escherichia coli from Clinical Specimens in Japan
Kayoko Hayakawa, Yusuke Tsuda, Shinya Tsuzuki, Yasufumi Matsumura, Norio Ohmagari
Acute development of EBV+ T-cell lymphoproliferative disorder after treatment with rituximab for follicular lymphoma
Satoko Oka, Yuta Watanabe, Yuina Ueda-Akagi, Takaya Mitsuyoshi, Kazuo Ono
Frequently asked questions
How long does it take to publish?
32 days from submission to decision after review; 88 days from submission to acceptance; 1 day from acceptance to online publication.
Reformat to Journal of Infection and Chemotherapy using Livewrite PremiumWhat are the publication costs?
Open Access APC: USD 3,000 (excluding taxes). Subscription publication: no publication fee charged to authors.
Reformat to Journal of Infection and Chemotherapy using Livewrite Premium